Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.04
- Piotroski Score 4.00
- Grade Equal-Weight
- Symbol (OMCL)
- Company Omnicell, Inc.
- Price $43.02
- Changes Percentage (1.63%)
- Change $0.69
- Day Low $42.68
- Day High $43.73
- Year High $46.48
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 10/31/2024
- Fiscal Year End N/A
- Average Stock Price Target $59.00
- High Stock Price Target $158.00
- Low Stock Price Target $39.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.46
- Trailing P/E Ratio -64.61
- Forward P/E Ratio -64.61
- P/E Growth -64.61
- Net Income $-20,371,000
Income Statement
Quarterly
Annual
Latest News of OMCL
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Investors in Omnicell (NASDAQ:OMCL) from three years ago are still down 71%, even after 3.4% gain this past week
Despite a recent 64% increase in Omnicell, Inc. (NASDAQ:OMCL) share price, the company has faced a 71% decline over the past three years....
By Yahoo! Finance | 6 days ago -
Is Now The Time To Look At Buying Omnicell, Inc. (NASDAQ:OMCL)?
Omnicell, Inc. (NASDAQ:OMCL) experienced notable price fluctuations, offering potential buying opportunities. Trading below intrinsic value at $28.26, the stock shows growth potential with earnings ex...
By Yahoo! Finance | 3 months ago
